[
    [
        {
            "time": "2021-11-27",
            "original_text": "复星医药11月27日召开股东大会审议复宏汉霖境外上市及仅向H股股东提供保证配额",
            "features": {
                "keywords": [
                    "复星医药",
                    "复宏汉霖",
                    "境外上市",
                    "股东大会"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药11月27日召开股东大会审议复宏汉霖境外上市及仅向H股股东提供保证配额",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-11-21",
            "original_text": "11月21日主力资金近三日都在买这些概念股，超级大单11只个股特大单净流入超亿元",
            "features": {
                "keywords": [
                    "主力资金",
                    "概念股",
                    "超级大单",
                    "净流入"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "11月21日主力资金近三日都在买这些概念股，超级大单11只个股特大单净流入超亿元",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-11-21",
            "original_text": "11月21日主力资金抢筹最积极的前10股（附名单）",
            "features": {
                "keywords": [
                    "主力资金",
                    "抢筹",
                    "前10股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "11月21日主力资金抢筹最积极的前10股（附名单）",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 4,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-11-27",
            "original_text": "[公告摘要]复星医药(02196.HK)11月27日召开股东大会审议复宏汉霖境外上市及仅向H股股东提供保证配额",
            "features": {
                "keywords": [
                    "复星医药",
                    "复宏汉霖",
                    "境外上市",
                    "股东大会",
                    "H股股东"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[公告摘要]复星医药(02196.HK)11月27日召开股东大会审议复宏汉霖境外上市及仅向H股股东提供保证配额",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-11-21",
            "original_text": "疫苗股大涨真相：三点预售、四点售罄，多地出现疫苗“一针难求”！",
            "features": {
                "keywords": [
                    "疫苗股",
                    "大涨",
                    "预售",
                    "售罄",
                    "一针难求"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "疫苗股大涨真相：三点预售、四点售罄，多地出现疫苗“一针难求”！",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-11-21",
            "original_text": "复星医药月底审议上市方案 独角兽复宏汉霖市值已达200亿",
            "features": {
                "keywords": [
                    "复星医药",
                    "复宏汉霖",
                    "上市方案",
                    "市值"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药月底审议上市方案 独角兽复宏汉霖市值已达200亿",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-11-21",
            "original_text": "复星医药子公司药友制药全国首家通过盐酸克林霉素胶囊一致性评价",
            "features": {
                "keywords": [
                    "复星医药",
                    "药友制药",
                    "一致性评价",
                    "盐酸克林霉素胶囊"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药子公司药友制药全国首家通过盐酸克林霉素胶囊一致性评价",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        }
    ]
]